No Data
No Data
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Unusual Options Activity: EXPE, ALAB and Others Attract Market Bets, EXPE V/OI Ratio Reaches 95.2
Express News | CNBC Halftime Report Final Trades: Copart, Amgen, Deere & Company, IShares U.S. Healthcare ETF
Express News | Amgen Inc : JP Morgan Raises Target Price to $300 From $290
Zenas Started at Buy by Four Banks on Lead Drug Potential
Obesity Drugs Seen Costing Medicare $35 Billion Through 2034